Cspc Pharmaceutical Hits One: year low as quarterly profit plunges
BUZZ-CSPC Pharmaceutical hits one-year low as quarterly profit plunges ** Shares of CSPC Pharmaceutical Group 1093.HK slide 10.8% to HK$6.64, their lowest level since May 27, 2025
** Stock on track for the biggest one-day pct decline since April 2025 in the second falling session
** Second biggest pct decliner in Hang Seng Biotech Index .HSBIO, which is down 0.5%
** Chinese pharmaceuticals products maker said its profit attributable to shareholders down 41.8% y/y to 859.8 mln yuan ($126.80 mln) for quarter ended March 31, with total revenue down 7.8% y/y to 6.47 bln yuan
** YTD, stock down 16%, benchmark Hang Seng Index .HSI down 1.1%
($1 = 6.7807 Chinese yuan renminbi)
(Reporting by Donny Kwok)
Recent news on CSPC PHARMACEUTICAL
See all newsBrief: CSPC Pharmaceutical Posts CSPC Innovation Pharmaceutical 9M Net Profit Attributable RMB 1.21 Billion
Brief: CSPC Pharmaceutical Publishes Updated Phase III OS Results For Anbenitamab In Her2-Positive Advanced Gastric Cancer
Brief: CSPC Pharmaceutical Says Batoclimab Injection (Enlida) Obtains Drug Registration Certificate From NMPA
Brief: CSPC Pharmaceutical Initiates Phase III Trial Of SYS6043 For Triple-Negative Breast Cancer In China
Factbox: Pharma sector doubles down on AI to slash costs, timelines